nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—ABCG2—Vemurafenib—melanoma	0.256	0.498	CbGbCtD
Clofarabine—ABCG2—Dactinomycin—melanoma	0.17	0.331	CbGbCtD
Clofarabine—ABCG2—Docetaxel—melanoma	0.0879	0.171	CbGbCtD
Clofarabine—RRM1—hair follicle—melanoma	0.0044	0.132	CbGeAlD
Clofarabine—POLA1—retina—melanoma	0.00274	0.0822	CbGeAlD
Clofarabine—RRM2—skin of body—melanoma	0.0023	0.0689	CbGeAlD
Clofarabine—RRM1—eye—melanoma	0.0022	0.0658	CbGeAlD
Clofarabine—POLA1—mammalian vulva—melanoma	0.0022	0.0658	CbGeAlD
Clofarabine—RRM1—retina—melanoma	0.00218	0.0652	CbGeAlD
Clofarabine—RRM2—mammalian vulva—melanoma	0.0021	0.0629	CbGeAlD
Clofarabine—RRM1—skin of body—melanoma	0.00191	0.0573	CbGeAlD
Clofarabine—RRM1—mammalian vulva—melanoma	0.00174	0.0522	CbGeAlD
Clofarabine—DCK—retina—melanoma	0.00169	0.0507	CbGeAlD
Clofarabine—RRM2—head—melanoma	0.0015	0.045	CbGeAlD
Clofarabine—DCK—mammalian vulva—melanoma	0.00135	0.0406	CbGeAlD
Clofarabine—RRM1—head—melanoma	0.00125	0.0374	CbGeAlD
Clofarabine—POLA1—lymph node—melanoma	0.0011	0.033	CbGeAlD
Clofarabine—RRM2—lymph node—melanoma	0.00105	0.0315	CbGeAlD
Clofarabine—DCK—head—melanoma	0.000969	0.029	CbGeAlD
Clofarabine—RRM1—lymph node—melanoma	0.000873	0.0262	CbGeAlD
Clofarabine—ABCG2—mammalian vulva—melanoma	0.000755	0.0226	CbGeAlD
Clofarabine—DCK—lymph node—melanoma	0.000678	0.0203	CbGeAlD
Clofarabine—Pneumonia—Temozolomide—melanoma	0.000571	0.00216	CcSEcCtD
Clofarabine—Infestation NOS—Temozolomide—melanoma	0.000568	0.00215	CcSEcCtD
Clofarabine—Infestation—Temozolomide—melanoma	0.000568	0.00215	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000563	0.00213	CcSEcCtD
Clofarabine—Flushing—Bleomycin—melanoma	0.000561	0.00212	CcSEcCtD
Clofarabine—Body temperature increased—Vemurafenib—melanoma	0.00056	0.00212	CcSEcCtD
Clofarabine—Neuropathy peripheral—Temozolomide—melanoma	0.000556	0.0021	CcSEcCtD
Clofarabine—Stomatitis—Temozolomide—melanoma	0.000553	0.00209	CcSEcCtD
Clofarabine—Deafness—Docetaxel—melanoma	0.000547	0.00207	CcSEcCtD
Clofarabine—Chills—Bleomycin—melanoma	0.000542	0.00205	CcSEcCtD
Clofarabine—Hepatobiliary disease—Temozolomide—melanoma	0.000537	0.00203	CcSEcCtD
Clofarabine—Alopecia—Bleomycin—melanoma	0.000534	0.00202	CcSEcCtD
Clofarabine—Erythema multiforme—Dactinomycin—melanoma	0.000533	0.00201	CcSEcCtD
Clofarabine—Sinusitis—Temozolomide—melanoma	0.000532	0.00201	CcSEcCtD
Clofarabine—Haemoglobin—Carmustine—melanoma	0.00053	0.002	CcSEcCtD
Clofarabine—Haemorrhage—Carmustine—melanoma	0.000527	0.00199	CcSEcCtD
Clofarabine—Erythema—Bleomycin—melanoma	0.000526	0.00199	CcSEcCtD
Clofarabine—Flushing—Dactinomycin—melanoma	0.000523	0.00198	CcSEcCtD
Clofarabine—Hypersensitivity—Vemurafenib—melanoma	0.000522	0.00197	CcSEcCtD
Clofarabine—Oedema peripheral—Carmustine—melanoma	0.000519	0.00196	CcSEcCtD
Clofarabine—Connective tissue disorder—Carmustine—melanoma	0.000518	0.00196	CcSEcCtD
Clofarabine—Haemoglobin—Temozolomide—melanoma	0.000512	0.00194	CcSEcCtD
Clofarabine—Haemorrhage—Temozolomide—melanoma	0.000509	0.00193	CcSEcCtD
Clofarabine—Asthenia—Vemurafenib—melanoma	0.000508	0.00192	CcSEcCtD
Clofarabine—Chills—Dactinomycin—melanoma	0.000505	0.00191	CcSEcCtD
Clofarabine—Urinary tract disorder—Temozolomide—melanoma	0.000503	0.0019	CcSEcCtD
Clofarabine—Oedema peripheral—Temozolomide—melanoma	0.000502	0.0019	CcSEcCtD
Clofarabine—Pruritus—Vemurafenib—melanoma	0.000501	0.0019	CcSEcCtD
Clofarabine—Connective tissue disorder—Temozolomide—melanoma	0.000501	0.00189	CcSEcCtD
Clofarabine—Lethargy—Docetaxel—melanoma	0.0005	0.00189	CcSEcCtD
Clofarabine—Urethral disorder—Temozolomide—melanoma	0.000499	0.00189	CcSEcCtD
Clofarabine—Alopecia—Dactinomycin—melanoma	0.000498	0.00188	CcSEcCtD
Clofarabine—Erythema—Dactinomycin—melanoma	0.00049	0.00186	CcSEcCtD
Clofarabine—Pain in extremity—Docetaxel—melanoma	0.00049	0.00185	CcSEcCtD
Clofarabine—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.00049	0.00185	CcSEcCtD
Clofarabine—Flushing—Carmustine—melanoma	0.000489	0.00185	CcSEcCtD
Clofarabine—Anaemia—Bleomycin—melanoma	0.000486	0.00184	CcSEcCtD
Clofarabine—Diarrhoea—Vemurafenib—melanoma	0.000485	0.00183	CcSEcCtD
Clofarabine—Erythema multiforme—Temozolomide—melanoma	0.000482	0.00182	CcSEcCtD
Clofarabine—Flushing—Temozolomide—melanoma	0.000473	0.00179	CcSEcCtD
Clofarabine—Cardiac disorder—Temozolomide—melanoma	0.000473	0.00179	CcSEcCtD
Clofarabine—Leukopenia—Bleomycin—melanoma	0.000471	0.00178	CcSEcCtD
Clofarabine—Dizziness—Vemurafenib—melanoma	0.000468	0.00177	CcSEcCtD
Clofarabine—Alopecia—Carmustine—melanoma	0.000466	0.00176	CcSEcCtD
Clofarabine—Angiopathy—Temozolomide—melanoma	0.000462	0.00175	CcSEcCtD
Clofarabine—Mental disorder—Carmustine—melanoma	0.000462	0.00175	CcSEcCtD
Clofarabine—Immune system disorder—Temozolomide—melanoma	0.00046	0.00174	CcSEcCtD
Clofarabine—Mediastinal disorder—Temozolomide—melanoma	0.000459	0.00174	CcSEcCtD
Clofarabine—Erythema—Carmustine—melanoma	0.000459	0.00174	CcSEcCtD
Clofarabine—Malnutrition—Carmustine—melanoma	0.000459	0.00174	CcSEcCtD
Clofarabine—Cough—Bleomycin—melanoma	0.000459	0.00174	CcSEcCtD
Clofarabine—Chills—Temozolomide—melanoma	0.000457	0.00173	CcSEcCtD
Clofarabine—Dehydration—Docetaxel—melanoma	0.000455	0.00172	CcSEcCtD
Clofarabine—Anaemia—Dactinomycin—melanoma	0.000453	0.00171	CcSEcCtD
Clofarabine—Vomiting—Vemurafenib—melanoma	0.00045	0.0017	CcSEcCtD
Clofarabine—Alopecia—Temozolomide—melanoma	0.00045	0.0017	CcSEcCtD
Clofarabine—Dry skin—Docetaxel—melanoma	0.000449	0.0017	CcSEcCtD
Clofarabine—Myalgia—Bleomycin—melanoma	0.000448	0.00169	CcSEcCtD
Clofarabine—Abdominal pain upper—Docetaxel—melanoma	0.000447	0.00169	CcSEcCtD
Clofarabine—Rash—Vemurafenib—melanoma	0.000447	0.00169	CcSEcCtD
Clofarabine—Mental disorder—Temozolomide—melanoma	0.000446	0.00169	CcSEcCtD
Clofarabine—Dermatitis—Vemurafenib—melanoma	0.000446	0.00169	CcSEcCtD
Clofarabine—Back pain—Carmustine—melanoma	0.000444	0.00168	CcSEcCtD
Clofarabine—Headache—Vemurafenib—melanoma	0.000444	0.00168	CcSEcCtD
Clofarabine—Malnutrition—Temozolomide—melanoma	0.000444	0.00168	CcSEcCtD
Clofarabine—Erythema—Temozolomide—melanoma	0.000444	0.00168	CcSEcCtD
Clofarabine—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000441	0.00167	CcSEcCtD
Clofarabine—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000441	0.00167	CcSEcCtD
Clofarabine—Leukopenia—Dactinomycin—melanoma	0.000439	0.00166	CcSEcCtD
Clofarabine—Alanine aminotransferase increased—Docetaxel—melanoma	0.000432	0.00163	CcSEcCtD
Clofarabine—Tremor—Carmustine—melanoma	0.00043	0.00163	CcSEcCtD
Clofarabine—Oedema—Bleomycin—melanoma	0.000429	0.00162	CcSEcCtD
Clofarabine—Back pain—Temozolomide—melanoma	0.000429	0.00162	CcSEcCtD
Clofarabine—Infection—Bleomycin—melanoma	0.000426	0.00161	CcSEcCtD
Clofarabine—Anaemia—Carmustine—melanoma	0.000424	0.0016	CcSEcCtD
Clofarabine—Agitation—Carmustine—melanoma	0.000422	0.0016	CcSEcCtD
Clofarabine—Nausea—Vemurafenib—melanoma	0.000421	0.00159	CcSEcCtD
Clofarabine—Thrombocytopenia—Bleomycin—melanoma	0.00042	0.00159	CcSEcCtD
Clofarabine—Myalgia—Dactinomycin—melanoma	0.000417	0.00158	CcSEcCtD
Clofarabine—Tremor—Temozolomide—melanoma	0.000416	0.00157	CcSEcCtD
Clofarabine—Leukopenia—Carmustine—melanoma	0.000411	0.00155	CcSEcCtD
Clofarabine—Anaemia—Temozolomide—melanoma	0.00041	0.00155	CcSEcCtD
Clofarabine—Anorexia—Bleomycin—melanoma	0.000409	0.00155	CcSEcCtD
Clofarabine—Agitation—Temozolomide—melanoma	0.000408	0.00154	CcSEcCtD
Clofarabine—Pancytopenia—Docetaxel—melanoma	0.000402	0.00152	CcSEcCtD
Clofarabine—Hypotension—Bleomycin—melanoma	0.000401	0.00152	CcSEcCtD
Clofarabine—Oedema—Dactinomycin—melanoma	0.0004	0.00151	CcSEcCtD
Clofarabine—Infection—Dactinomycin—melanoma	0.000398	0.0015	CcSEcCtD
Clofarabine—Leukopenia—Temozolomide—melanoma	0.000397	0.0015	CcSEcCtD
Clofarabine—Hypertension—Carmustine—melanoma	0.000396	0.0015	CcSEcCtD
Clofarabine—Neutropenia—Docetaxel—melanoma	0.000396	0.0015	CcSEcCtD
Clofarabine—Thrombocytopenia—Dactinomycin—melanoma	0.000392	0.00148	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000391	0.00148	CcSEcCtD
Clofarabine—Myalgia—Carmustine—melanoma	0.000391	0.00148	CcSEcCtD
Clofarabine—Anxiety—Carmustine—melanoma	0.000389	0.00147	CcSEcCtD
Clofarabine—Cough—Temozolomide—melanoma	0.000387	0.00146	CcSEcCtD
Clofarabine—Paraesthesia—Bleomycin—melanoma	0.000385	0.00146	CcSEcCtD
Clofarabine—Weight decreased—Docetaxel—melanoma	0.000383	0.00145	CcSEcCtD
Clofarabine—Hypertension—Temozolomide—melanoma	0.000383	0.00145	CcSEcCtD
Clofarabine—Dyspnoea—Bleomycin—melanoma	0.000383	0.00145	CcSEcCtD
Clofarabine—Anorexia—Dactinomycin—melanoma	0.000381	0.00144	CcSEcCtD
Clofarabine—Pneumonia—Docetaxel—melanoma	0.00038	0.00144	CcSEcCtD
Clofarabine—ABCG2—lymph node—melanoma	0.000378	0.0113	CbGeAlD
Clofarabine—Arthralgia—Temozolomide—melanoma	0.000378	0.00143	CcSEcCtD
Clofarabine—Myalgia—Temozolomide—melanoma	0.000378	0.00143	CcSEcCtD
Clofarabine—Infestation NOS—Docetaxel—melanoma	0.000377	0.00143	CcSEcCtD
Clofarabine—Infestation—Docetaxel—melanoma	0.000377	0.00143	CcSEcCtD
Clofarabine—Anxiety—Temozolomide—melanoma	0.000376	0.00142	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000375	0.00142	CcSEcCtD
Clofarabine—Oedema—Carmustine—melanoma	0.000375	0.00142	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000374	0.00142	CcSEcCtD
Clofarabine—Decreased appetite—Bleomycin—melanoma	0.000373	0.00141	CcSEcCtD
Clofarabine—Infection—Carmustine—melanoma	0.000372	0.00141	CcSEcCtD
Clofarabine—Renal failure—Docetaxel—melanoma	0.000371	0.0014	CcSEcCtD
Clofarabine—Neuropathy peripheral—Docetaxel—melanoma	0.00037	0.0014	CcSEcCtD
Clofarabine—Jaundice—Docetaxel—melanoma	0.000368	0.00139	CcSEcCtD
Clofarabine—Stomatitis—Docetaxel—melanoma	0.000368	0.00139	CcSEcCtD
Clofarabine—Pain—Bleomycin—melanoma	0.000367	0.00139	CcSEcCtD
Clofarabine—Thrombocytopenia—Carmustine—melanoma	0.000367	0.00139	CcSEcCtD
Clofarabine—Tachycardia—Carmustine—melanoma	0.000366	0.00138	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000365	0.00138	CcSEcCtD
Clofarabine—Oedema—Temozolomide—melanoma	0.000362	0.00137	CcSEcCtD
Clofarabine—Infection—Temozolomide—melanoma	0.00036	0.00136	CcSEcCtD
Clofarabine—Anorexia—Carmustine—melanoma	0.000357	0.00135	CcSEcCtD
Clofarabine—Hepatobiliary disease—Docetaxel—melanoma	0.000357	0.00135	CcSEcCtD
Clofarabine—Epistaxis—Docetaxel—melanoma	0.000356	0.00135	CcSEcCtD
Clofarabine—Nervous system disorder—Temozolomide—melanoma	0.000355	0.00134	CcSEcCtD
Clofarabine—Thrombocytopenia—Temozolomide—melanoma	0.000354	0.00134	CcSEcCtD
Clofarabine—Feeling abnormal—Bleomycin—melanoma	0.000354	0.00134	CcSEcCtD
Clofarabine—Skin disorder—Temozolomide—melanoma	0.000352	0.00133	CcSEcCtD
Clofarabine—Hypotension—Carmustine—melanoma	0.00035	0.00132	CcSEcCtD
Clofarabine—Hyperhidrosis—Temozolomide—melanoma	0.00035	0.00132	CcSEcCtD
Clofarabine—Decreased appetite—Dactinomycin—melanoma	0.000348	0.00132	CcSEcCtD
Clofarabine—Fatigue—Dactinomycin—melanoma	0.000345	0.00131	CcSEcCtD
Clofarabine—Anorexia—Temozolomide—melanoma	0.000345	0.00131	CcSEcCtD
Clofarabine—Pain—Dactinomycin—melanoma	0.000342	0.00129	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Carmustine—melanoma	0.000341	0.00129	CcSEcCtD
Clofarabine—Haemoglobin—Docetaxel—melanoma	0.000341	0.00129	CcSEcCtD
Clofarabine—Body temperature increased—Bleomycin—melanoma	0.000339	0.00128	CcSEcCtD
Clofarabine—Haemorrhage—Docetaxel—melanoma	0.000339	0.00128	CcSEcCtD
Clofarabine—Paraesthesia—Carmustine—melanoma	0.000336	0.00127	CcSEcCtD
Clofarabine—Urinary tract disorder—Docetaxel—melanoma	0.000335	0.00127	CcSEcCtD
Clofarabine—Dyspnoea—Carmustine—melanoma	0.000334	0.00126	CcSEcCtD
Clofarabine—Oedema peripheral—Docetaxel—melanoma	0.000334	0.00126	CcSEcCtD
Clofarabine—Somnolence—Carmustine—melanoma	0.000333	0.00126	CcSEcCtD
Clofarabine—Connective tissue disorder—Docetaxel—melanoma	0.000333	0.00126	CcSEcCtD
Clofarabine—Urethral disorder—Docetaxel—melanoma	0.000332	0.00126	CcSEcCtD
Clofarabine—Feeling abnormal—Dactinomycin—melanoma	0.00033	0.00125	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Temozolomide—melanoma	0.00033	0.00125	CcSEcCtD
Clofarabine—Gastrointestinal pain—Dactinomycin—melanoma	0.000327	0.00124	CcSEcCtD
Clofarabine—Decreased appetite—Carmustine—melanoma	0.000326	0.00123	CcSEcCtD
Clofarabine—Paraesthesia—Temozolomide—melanoma	0.000325	0.00123	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Carmustine—melanoma	0.000323	0.00122	CcSEcCtD
Clofarabine—Dyspnoea—Temozolomide—melanoma	0.000323	0.00122	CcSEcCtD
Clofarabine—Somnolence—Temozolomide—melanoma	0.000322	0.00122	CcSEcCtD
Clofarabine—Erythema multiforme—Docetaxel—melanoma	0.00032	0.00121	CcSEcCtD
Clofarabine—Pain—Carmustine—melanoma	0.00032	0.00121	CcSEcCtD
Clofarabine—Abdominal pain—Dactinomycin—melanoma	0.000316	0.0012	CcSEcCtD
Clofarabine—Body temperature increased—Dactinomycin—melanoma	0.000316	0.0012	CcSEcCtD
Clofarabine—Hypersensitivity—Bleomycin—melanoma	0.000316	0.0012	CcSEcCtD
Clofarabine—Decreased appetite—Temozolomide—melanoma	0.000315	0.00119	CcSEcCtD
Clofarabine—Cardiac disorder—Docetaxel—melanoma	0.000314	0.00119	CcSEcCtD
Clofarabine—Flushing—Docetaxel—melanoma	0.000314	0.00119	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Temozolomide—melanoma	0.000313	0.00118	CcSEcCtD
Clofarabine—Fatigue—Temozolomide—melanoma	0.000312	0.00118	CcSEcCtD
Clofarabine—Pain—Temozolomide—melanoma	0.00031	0.00117	CcSEcCtD
Clofarabine—Feeling abnormal—Carmustine—melanoma	0.000309	0.00117	CcSEcCtD
Clofarabine—Asthenia—Bleomycin—melanoma	0.000308	0.00116	CcSEcCtD
Clofarabine—Angiopathy—Docetaxel—melanoma	0.000307	0.00116	CcSEcCtD
Clofarabine—Gastrointestinal pain—Carmustine—melanoma	0.000306	0.00116	CcSEcCtD
Clofarabine—Immune system disorder—Docetaxel—melanoma	0.000306	0.00116	CcSEcCtD
Clofarabine—Mediastinal disorder—Docetaxel—melanoma	0.000305	0.00116	CcSEcCtD
Clofarabine—Chills—Docetaxel—melanoma	0.000304	0.00115	CcSEcCtD
Clofarabine—Pruritus—Bleomycin—melanoma	0.000304	0.00115	CcSEcCtD
Clofarabine—Alopecia—Docetaxel—melanoma	0.000299	0.00113	CcSEcCtD
Clofarabine—Feeling abnormal—Temozolomide—melanoma	0.000298	0.00113	CcSEcCtD
Clofarabine—Mental disorder—Docetaxel—melanoma	0.000297	0.00112	CcSEcCtD
Clofarabine—Abdominal pain—Carmustine—melanoma	0.000296	0.00112	CcSEcCtD
Clofarabine—Body temperature increased—Carmustine—melanoma	0.000296	0.00112	CcSEcCtD
Clofarabine—Gastrointestinal pain—Temozolomide—melanoma	0.000296	0.00112	CcSEcCtD
Clofarabine—Erythema—Docetaxel—melanoma	0.000295	0.00112	CcSEcCtD
Clofarabine—Malnutrition—Docetaxel—melanoma	0.000295	0.00112	CcSEcCtD
Clofarabine—Hypersensitivity—Dactinomycin—melanoma	0.000295	0.00112	CcSEcCtD
Clofarabine—Asthenia—Dactinomycin—melanoma	0.000287	0.00109	CcSEcCtD
Clofarabine—Body temperature increased—Temozolomide—melanoma	0.000286	0.00108	CcSEcCtD
Clofarabine—Abdominal pain—Temozolomide—melanoma	0.000286	0.00108	CcSEcCtD
Clofarabine—Back pain—Docetaxel—melanoma	0.000285	0.00108	CcSEcCtD
Clofarabine—Hypersensitivity—Carmustine—melanoma	0.000276	0.00104	CcSEcCtD
Clofarabine—Diarrhoea—Dactinomycin—melanoma	0.000274	0.00104	CcSEcCtD
Clofarabine—Vomiting—Bleomycin—melanoma	0.000273	0.00103	CcSEcCtD
Clofarabine—Anaemia—Docetaxel—melanoma	0.000273	0.00103	CcSEcCtD
Clofarabine—Rash—Bleomycin—melanoma	0.000271	0.00102	CcSEcCtD
Clofarabine—Dermatitis—Bleomycin—melanoma	0.00027	0.00102	CcSEcCtD
Clofarabine—Asthenia—Carmustine—melanoma	0.000269	0.00102	CcSEcCtD
Clofarabine—Hypersensitivity—Temozolomide—melanoma	0.000267	0.00101	CcSEcCtD
Clofarabine—Leukopenia—Docetaxel—melanoma	0.000264	0.000999	CcSEcCtD
Clofarabine—Asthenia—Temozolomide—melanoma	0.00026	0.000983	CcSEcCtD
Clofarabine—Cough—Docetaxel—melanoma	0.000257	0.000974	CcSEcCtD
Clofarabine—Diarrhoea—Carmustine—melanoma	0.000256	0.00097	CcSEcCtD
Clofarabine—Pruritus—Temozolomide—melanoma	0.000256	0.000969	CcSEcCtD
Clofarabine—Nausea—Bleomycin—melanoma	0.000255	0.000964	CcSEcCtD
Clofarabine—Hypertension—Docetaxel—melanoma	0.000255	0.000963	CcSEcCtD
Clofarabine—Vomiting—Dactinomycin—melanoma	0.000254	0.000963	CcSEcCtD
Clofarabine—Rash—Dactinomycin—melanoma	0.000252	0.000955	CcSEcCtD
Clofarabine—Myalgia—Docetaxel—melanoma	0.000251	0.00095	CcSEcCtD
Clofarabine—Arthralgia—Docetaxel—melanoma	0.000251	0.00095	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000249	0.000943	CcSEcCtD
Clofarabine—Dizziness—Carmustine—melanoma	0.000248	0.000937	CcSEcCtD
Clofarabine—Diarrhoea—Temozolomide—melanoma	0.000248	0.000937	CcSEcCtD
Clofarabine—Oedema—Docetaxel—melanoma	0.000241	0.000911	CcSEcCtD
Clofarabine—Dizziness—Temozolomide—melanoma	0.000239	0.000906	CcSEcCtD
Clofarabine—Infection—Docetaxel—melanoma	0.000239	0.000905	CcSEcCtD
Clofarabine—Vomiting—Carmustine—melanoma	0.000238	0.000901	CcSEcCtD
Clofarabine—Nausea—Dactinomycin—melanoma	0.000238	0.000899	CcSEcCtD
Clofarabine—Rash—Carmustine—melanoma	0.000236	0.000893	CcSEcCtD
Clofarabine—Nervous system disorder—Docetaxel—melanoma	0.000236	0.000893	CcSEcCtD
Clofarabine—Dermatitis—Carmustine—melanoma	0.000236	0.000893	CcSEcCtD
Clofarabine—Thrombocytopenia—Docetaxel—melanoma	0.000236	0.000892	CcSEcCtD
Clofarabine—Tachycardia—Docetaxel—melanoma	0.000235	0.000889	CcSEcCtD
Clofarabine—Headache—Carmustine—melanoma	0.000235	0.000888	CcSEcCtD
Clofarabine—Skin disorder—Docetaxel—melanoma	0.000234	0.000885	CcSEcCtD
Clofarabine—Vomiting—Temozolomide—melanoma	0.00023	0.000871	CcSEcCtD
Clofarabine—Anorexia—Docetaxel—melanoma	0.000229	0.000868	CcSEcCtD
Clofarabine—Rash—Temozolomide—melanoma	0.000228	0.000863	CcSEcCtD
Clofarabine—Dermatitis—Temozolomide—melanoma	0.000228	0.000863	CcSEcCtD
Clofarabine—Headache—Temozolomide—melanoma	0.000227	0.000858	CcSEcCtD
Clofarabine—Hypotension—Docetaxel—melanoma	0.000225	0.000851	CcSEcCtD
Clofarabine—Nausea—Carmustine—melanoma	0.000222	0.000842	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000219	0.00083	CcSEcCtD
Clofarabine—Paraesthesia—Docetaxel—melanoma	0.000216	0.000818	CcSEcCtD
Clofarabine—Nausea—Temozolomide—melanoma	0.000215	0.000813	CcSEcCtD
Clofarabine—Dyspnoea—Docetaxel—melanoma	0.000215	0.000812	CcSEcCtD
Clofarabine—Somnolence—Docetaxel—melanoma	0.000214	0.00081	CcSEcCtD
Clofarabine—Decreased appetite—Docetaxel—melanoma	0.000209	0.000792	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Docetaxel—melanoma	0.000208	0.000786	CcSEcCtD
Clofarabine—Fatigue—Docetaxel—melanoma	0.000208	0.000785	CcSEcCtD
Clofarabine—Pain—Docetaxel—melanoma	0.000206	0.000779	CcSEcCtD
Clofarabine—Feeling abnormal—Docetaxel—melanoma	0.000198	0.00075	CcSEcCtD
Clofarabine—Gastrointestinal pain—Docetaxel—melanoma	0.000197	0.000745	CcSEcCtD
Clofarabine—Abdominal pain—Docetaxel—melanoma	0.00019	0.00072	CcSEcCtD
Clofarabine—Body temperature increased—Docetaxel—melanoma	0.00019	0.00072	CcSEcCtD
Clofarabine—Hypersensitivity—Docetaxel—melanoma	0.000177	0.000671	CcSEcCtD
Clofarabine—Asthenia—Docetaxel—melanoma	0.000173	0.000653	CcSEcCtD
Clofarabine—Pruritus—Docetaxel—melanoma	0.00017	0.000644	CcSEcCtD
Clofarabine—Diarrhoea—Docetaxel—melanoma	0.000165	0.000623	CcSEcCtD
Clofarabine—Dizziness—Docetaxel—melanoma	0.000159	0.000602	CcSEcCtD
Clofarabine—DCK—Metabolism—SLC6A11—melanoma	0.000154	0.000817	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIP4K2A—melanoma	0.000154	0.000817	CbGpPWpGaD
Clofarabine—Vomiting—Docetaxel—melanoma	0.000153	0.000579	CcSEcCtD
Clofarabine—ABCG2—Fluoropyrimidine Activity—TP53—melanoma	0.000153	0.000814	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN2B—melanoma	0.000153	0.000812	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	0.000153	0.000812	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—SKP2—melanoma	0.000152	0.000809	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—APC—melanoma	0.000152	0.000808	CbGpPWpGaD
Clofarabine—Rash—Docetaxel—melanoma	0.000152	0.000574	CcSEcCtD
Clofarabine—Dermatitis—Docetaxel—melanoma	0.000152	0.000574	CcSEcCtD
Clofarabine—Headache—Docetaxel—melanoma	0.000151	0.000571	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	0.00015	0.000799	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC15A2—melanoma	0.00015	0.000799	CbGpPWpGaD
Clofarabine—DCK—Metabolism—MTAP—melanoma	0.00015	0.000795	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	0.000149	0.00079	CbGpPWpGaD
Clofarabine—POLA1—S Phase—CCND1—melanoma	0.000148	0.000788	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	0.000145	0.000772	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	0.000145	0.000772	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000145	0.000769	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—melanoma	0.000144	0.000767	CbGpPWpGaD
Clofarabine—POLA1—S Phase—CDKN1A—melanoma	0.000143	0.000763	CbGpPWpGaD
Clofarabine—Nausea—Docetaxel—melanoma	0.000143	0.000541	CcSEcCtD
Clofarabine—RRM2—Metabolism—PHGDH—melanoma	0.000143	0.000758	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—LUM—melanoma	0.000143	0.000758	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	0.000142	0.000753	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—E2F1—melanoma	0.00014	0.000746	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—HPSE—melanoma	0.00014	0.000743	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	0.000139	0.00074	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—AURKA—melanoma	0.000139	0.00074	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	0.000138	0.000736	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CCND1—melanoma	0.000138	0.000732	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MLH1—melanoma	0.000138	0.000731	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—PRKCA—melanoma	0.000137	0.00073	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CUBN—melanoma	0.000137	0.00073	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	0.000137	0.00073	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN2B—melanoma	0.000137	0.000726	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—SKP2—melanoma	0.000136	0.000723	CbGpPWpGaD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—melanoma	0.000136	0.000722	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	0.000135	0.000715	CbGpPWpGaD
Clofarabine—DCK—Metabolism—LUM—melanoma	0.000133	0.000708	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PHGDH—melanoma	0.000133	0.000708	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDKN1A—melanoma	0.000133	0.000708	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—SDHD—melanoma	0.000133	0.000705	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—BSG—melanoma	0.000133	0.000705	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CSPG4—melanoma	0.000133	0.000705	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PLA2G6—melanoma	0.000133	0.000705	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—PCNA—melanoma	0.000132	0.000703	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC6A11—melanoma	0.000131	0.000698	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—MYC—melanoma	0.000131	0.000697	CbGpPWpGaD
Clofarabine—DCK—Metabolism—HPSE—melanoma	0.000131	0.000695	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—melanoma	0.000129	0.000685	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GPAM—melanoma	0.000128	0.000683	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CUBN—melanoma	0.000128	0.000682	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—E2F1—melanoma	0.000128	0.000682	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	0.000128	0.00068	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	0.000126	0.00067	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—PRKCA—melanoma	0.000126	0.000668	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—E2F1—melanoma	0.000125	0.000667	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—AURKA—melanoma	0.000124	0.000661	CbGpPWpGaD
Clofarabine—DCK—Metabolism—SDHD—melanoma	0.000124	0.000659	CbGpPWpGaD
Clofarabine—DCK—Metabolism—BSG—melanoma	0.000124	0.000659	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CSPG4—melanoma	0.000124	0.000659	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—PRKCA—melanoma	0.000123	0.000653	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	0.000122	0.000648	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	0.000122	0.000646	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDK2—melanoma	0.000121	0.000643	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—APEX1—melanoma	0.000121	0.000642	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GPAM—melanoma	0.00012	0.000638	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	0.00012	0.000637	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—VCAN—melanoma	0.000119	0.000633	CbGpPWpGaD
Clofarabine—POLA1—S Phase—MYC—melanoma	0.000119	0.000632	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—PCNA—melanoma	0.000118	0.000629	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	0.000118	0.000628	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—melanoma	0.000116	0.000618	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	0.000115	0.000614	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDK4—melanoma	0.000114	0.000608	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TERT—melanoma	0.000114	0.000607	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—CDK2—melanoma	0.000111	0.000588	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—MYC—melanoma	0.00011	0.000587	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	0.000109	0.000581	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PLA2G6—melanoma	0.000109	0.00058	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDK2—melanoma	0.000108	0.000575	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—APEX1—melanoma	0.000108	0.000574	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	0.000107	0.00057	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN2B—melanoma	0.000105	0.000556	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	0.000104	0.000554	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	0.000103	0.000549	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	0.000103	0.000548	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—ATM—melanoma	0.000103	0.000546	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDK4—melanoma	0.000102	0.000543	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PLA2G6—melanoma	0.000102	0.000542	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ACER3—melanoma	0.000102	0.00054	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	0.000101	0.000536	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	0.000101	0.000535	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CYP17A1—melanoma	0.0001	0.000534	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.0001	0.000533	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—RB1—melanoma	9.94e-05	0.000528	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—VCAN—melanoma	9.81e-05	0.000521	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—E2F1—melanoma	9.59e-05	0.00051	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GNA11—melanoma	9.49e-05	0.000504	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—PRKCA—melanoma	9.4e-05	0.0005	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN2B—melanoma	9.34e-05	0.000497	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—FASN—melanoma	9.28e-05	0.000494	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—UGT2B10—melanoma	9.28e-05	0.000494	CbGpPWpGaD
Clofarabine—DCK—Metabolism—VCAN—melanoma	9.16e-05	0.000487	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—SLC5A5—melanoma	9.13e-05	0.000486	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	9.09e-05	0.000483	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—RB1—melanoma	9.09e-05	0.000483	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—PCNA—melanoma	9.05e-05	0.000481	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—RB1—melanoma	8.89e-05	0.000472	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GNAQ—melanoma	8.82e-05	0.000469	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CD44—melanoma	8.82e-05	0.000469	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN2A—melanoma	8.74e-05	0.000465	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—HS3ST5—melanoma	8.63e-05	0.000459	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	8.6e-05	0.000457	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—E2F1—melanoma	8.58e-05	0.000456	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CYP1B1—melanoma	8.46e-05	0.00045	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—PRKCA—melanoma	8.4e-05	0.000447	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	8.37e-05	0.000445	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP17A1—melanoma	8.27e-05	0.00044	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDK2—melanoma	8.27e-05	0.00044	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	8.18e-05	0.000435	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	8.18e-05	0.000435	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—PCNA—melanoma	8.09e-05	0.00043	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDK4—melanoma	7.82e-05	0.000416	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GNA11—melanoma	7.81e-05	0.000415	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN2A—melanoma	7.81e-05	0.000415	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TERT—melanoma	7.81e-05	0.000415	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	7.79e-05	0.000414	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN1B—melanoma	7.74e-05	0.000411	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP17A1—melanoma	7.73e-05	0.000411	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	7.73e-05	0.000411	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—FASN—melanoma	7.65e-05	0.000406	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MDM2—melanoma	7.58e-05	0.000403	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—SLC5A5—melanoma	7.52e-05	0.0004	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—AKT1—melanoma	7.42e-05	0.000395	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDK2—melanoma	7.4e-05	0.000393	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CCND1—melanoma	7.38e-05	0.000392	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GNA11—melanoma	7.3e-05	0.000388	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CD44—melanoma	7.26e-05	0.000386	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GNAQ—melanoma	7.26e-05	0.000386	CbGpPWpGaD
Clofarabine—DCK—Metabolism—FASN—melanoma	7.14e-05	0.00038	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN1A—melanoma	7.14e-05	0.00038	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	7.1e-05	0.000378	CbGpPWpGaD
Clofarabine—DCK—Metabolism—SLC5A5—melanoma	7.03e-05	0.000374	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—ATM—melanoma	7.02e-05	0.000373	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDK4—melanoma	6.99e-05	0.000372	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ABCB1—melanoma	6.96e-05	0.00037	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP1B1—melanoma	6.96e-05	0.00037	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN1B—melanoma	6.92e-05	0.000368	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	6.87e-05	0.000365	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—RB1—melanoma	6.8e-05	0.000361	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GNAQ—melanoma	6.79e-05	0.000361	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CD44—melanoma	6.79e-05	0.000361	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CCND1—melanoma	6.6e-05	0.000351	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PLCB4—melanoma	6.54e-05	0.000348	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP1B1—melanoma	6.51e-05	0.000346	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PRKCA—melanoma	6.41e-05	0.000341	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN1A—melanoma	6.39e-05	0.000339	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ERCC2—melanoma	6.36e-05	0.000338	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIP4K2A—melanoma	6.15e-05	0.000327	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SLC6A11—melanoma	6.15e-05	0.000327	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—MAPK3—melanoma	6.09e-05	0.000324	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—RB1—melanoma	6.08e-05	0.000323	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC5A5—melanoma	6e-05	0.000319	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—MTAP—melanoma	5.98e-05	0.000318	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—melanoma	5.98e-05	0.000318	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—MYC—melanoma	5.92e-05	0.000315	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	5.8e-05	0.000308	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—MAPK1—melanoma	5.79e-05	0.000308	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ABCB1—melanoma	5.73e-05	0.000305	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—MAPK3—melanoma	5.57e-05	0.000296	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MAPK3—melanoma	5.44e-05	0.000289	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ABCB1—melanoma	5.36e-05	0.000285	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN2A—melanoma	5.34e-05	0.000284	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PHGDH—melanoma	5.33e-05	0.000283	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—LUM—melanoma	5.33e-05	0.000283	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—MAPK1—melanoma	5.3e-05	0.000282	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MYC—melanoma	5.29e-05	0.000281	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—melanoma	5.29e-05	0.000281	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PRKCA—melanoma	5.28e-05	0.000281	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ERCC2—melanoma	5.23e-05	0.000278	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—HPSE—melanoma	5.23e-05	0.000278	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MDM2—melanoma	5.18e-05	0.000276	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MAPK1—melanoma	5.18e-05	0.000275	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CUBN—melanoma	5.13e-05	0.000273	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CCND1—melanoma	5.05e-05	0.000268	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CG—melanoma	5.02e-05	0.000267	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SDHD—melanoma	4.96e-05	0.000264	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—BSG—melanoma	4.96e-05	0.000264	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CSPG4—melanoma	4.96e-05	0.000264	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PRKCA—melanoma	4.93e-05	0.000262	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ERCC2—melanoma	4.89e-05	0.00026	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN1A—melanoma	4.88e-05	0.00026	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PPARG—melanoma	4.84e-05	0.000258	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GPAM—melanoma	4.8e-05	0.000255	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN1B—melanoma	4.73e-05	0.000252	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ABCB1—melanoma	4.58e-05	0.000243	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CCND1—melanoma	4.51e-05	0.00024	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CD—melanoma	4.41e-05	0.000235	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN1A—melanoma	4.37e-05	0.000232	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ALB—melanoma	4.36e-05	0.000232	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TP53—melanoma	4.35e-05	0.000231	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MAPK3—melanoma	4.16e-05	0.000221	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CG—melanoma	4.13e-05	0.00022	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PLA2G6—melanoma	4.08e-05	0.000217	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MYC—melanoma	4.05e-05	0.000215	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PPARG—melanoma	3.99e-05	0.000212	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MAPK1—melanoma	3.96e-05	0.000211	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CG—melanoma	3.86e-05	0.000205	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CB—melanoma	3.85e-05	0.000204	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PTGS2—melanoma	3.81e-05	0.000203	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PPARG—melanoma	3.73e-05	0.000198	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MAPK3—melanoma	3.72e-05	0.000198	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—VCAN—melanoma	3.67e-05	0.000195	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CD—melanoma	3.63e-05	0.000193	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MYC—melanoma	3.62e-05	0.000193	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ALB—melanoma	3.59e-05	0.000191	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MAPK1—melanoma	3.54e-05	0.000188	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CD—melanoma	3.4e-05	0.000181	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ALB—melanoma	3.35e-05	0.000178	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PTEN—melanoma	3.32e-05	0.000177	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CB—melanoma	3.17e-05	0.000168	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PTGS2—melanoma	3.14e-05	0.000167	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP17A1—melanoma	3.09e-05	0.000164	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TP53—melanoma	2.97e-05	0.000158	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CB—melanoma	2.96e-05	0.000157	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTGS2—melanoma	2.93e-05	0.000156	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GNA11—melanoma	2.92e-05	0.000155	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ALB—melanoma	2.86e-05	0.000152	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—FASN—melanoma	2.86e-05	0.000152	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SLC5A5—melanoma	2.81e-05	0.00015	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PTEN—melanoma	2.74e-05	0.000146	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GNAQ—melanoma	2.72e-05	0.000144	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CD44—melanoma	2.72e-05	0.000144	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP1B1—melanoma	2.6e-05	0.000138	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTEN—melanoma	2.56e-05	0.000136	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CA—melanoma	2.34e-05	0.000125	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ABCB1—melanoma	2.14e-05	0.000114	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PRKCA—melanoma	1.97e-05	0.000105	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ERCC2—melanoma	1.96e-05	0.000104	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CA—melanoma	1.93e-05	0.000103	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—AKT1—melanoma	1.92e-05	0.000102	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CA—melanoma	1.8e-05	9.59e-05	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—AKT1—melanoma	1.58e-05	8.39e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CG—melanoma	1.55e-05	8.22e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PPARG—melanoma	1.49e-05	7.93e-05	CbGpPWpGaD
Clofarabine—DCK—Metabolism—AKT1—melanoma	1.47e-05	7.84e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CD—melanoma	1.36e-05	7.22e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ALB—melanoma	1.34e-05	7.13e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CB—melanoma	1.18e-05	6.3e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTGS2—melanoma	1.17e-05	6.24e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTEN—melanoma	1.02e-05	5.44e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CA—melanoma	7.22e-06	3.84e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—AKT1—melanoma	5.9e-06	3.14e-05	CbGpPWpGaD
